Marex (MRX) EBT (2023 - 2026)

Marex (MRX) has reported EBT for 4 consecutive years, with $155.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 45.96% year-over-year to $155.3 million; the trailing twelve-month figure through Jun 2026 stood at $519.7 million (down 14.0% YoY), and the FY2025 full-year result was $411.6 million, up 39.15% from the prior year.
• EBT advanced to $155.3 million in Q2 2026 per MRX's latest filing, from $152.7 million in the prior quarter.
• Across five years, EBT topped out at $321.1 million in Q4 2024 and bottomed at $52.6 million in Q4 2023.
• Historically, EBT has averaged $121.4 million across 4 years, with a median of $100.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: EBT soared 510.46% in 2024, then plunged 65.37% in 2025.
• Over 4 years, EBT stood at $52.6 million in 2023, then jumped by 510.46% to $321.1 million in 2024, then slumped by 65.37% to $111.2 million in 2025, then surged by 39.66% to $155.3 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $155.3 million, $152.7 million, and $111.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.